查看购物车
  • Traditional Chinese
  • English
2021-2031年北美客製化抗体服务市场报告：范围、细分、动态和竞争分析
市场调查报告书
商品编码
1871504

2021-2031年北美客製化抗体服务市场报告：范围、细分、动态和竞争分析

North America Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 订单完成后即时交付

价格

预计北美客製化抗体服务市场将大幅成长，到 2031 年将达到约 5.7776 亿美元，高于 2023 年的 2.8749 亿美元，2023 年至 2031 年的年复合成长率(CAGR) 预计为 9.1%。

执行摘要和市场分析

北美客製化抗体服务市场主要分为美国、加拿大和墨西哥三大区域。推动该市场成长的因素众多，包括先进技术的日益普及、药物研发投入的不断增加、政府对临床研究的大力支持以及临床诊断研究活动的蓬勃发展。此外，政府机构与市场参与者之间的合作也促进了客製化抗体在临床诊断中的应用。美国和加拿大癌症及基因组研究计画的不断涌现，以及对抗体疗法研发的重视，也推动了市场扩张。对高品质研究工具的需求，以确保资料可重复性，进一步促进了北美客製化抗体服务市场的成长。

市场区隔分析

北美客製化抗体服务市场可根据产品类型、服务类型、应用、疾病适应症、来源和最终用户进行细分：

  • 产品类型：市场可分为单株抗体、多株抗体、杂交瘤抗体、重组抗体及其他抗体。 2023年，单株抗体占最大的市占率。
  • 服务类型：此细分市场包括抗体发现和开发、抗体生产服务等，其中抗体发现和开发在 2023 年的市场份额中领先。
  • 应用领域：应用包括免疫组织化学、蛋白质印迹和免疫沉淀（IP）、酵素连结免疫吸附试验（ELISA）、萤光活化细胞分选、质谱分析等。其中，ELISA是2023年最重要的应用。
  • 疾病适应症：市场分为肿瘤学、传染病学、免疫学、心血管疾病和其他领域，其中肿瘤学是 2023 年最大的细分市场。
  • 资料来源：这包括鸡、兔、大鼠、豚鼠和小鼠或人源化小鼠，其中后者在 2023 年占据最大份额。此部分进一步细分为单株抗体和其他技术的各种平台。
  • 最终用户：最终用户包括生命科学产业、製药和生物技术公司、学术和研究机构以及合约研究组织，其中生命科学产业在 2023 年的市占率领先。

市场展望

FDA在批准生物相似药方面发挥着至关重要的作用，生物相似药的审批通过提供更多药物选择并可能降低成本，从而改善患者护理。近期获准的生物相似药，例如Alymsys和Cimerli，大大拓展了治疗选择。 FDA批准的生物相似药数量不断增加，预计将推动客製化抗体服务市场的成长，因为它们可以降低治疗成本并提高生物疗法的可及性。

国家概况

北美客製化抗体服务市场主要由美国驱动，美国在2023年占据最大市场份额。美国传染病、慢性病和自体免疫疾病发生率的上升，推动了对客製化抗体服务的需求成长。癌症仍是主要的死亡原因之一，2022年新增病例超过190万例，预计2024年新增病例将达到约200万例。客製化抗体在癌症治疗中至关重要，可用于检测肿瘤特异性抗原和监测患者病情进展。美国市场受益于研发投入的增加以及客製化抗体在包括肿瘤学和免疫学在内的各个研究领域中日益广泛的应用。

公司简介

客製化抗体服务市场的主要参与者包括 Thermo Fisher Scientific Inc.、Sino Biological Inc.、GenScript Biotech Corporation、Biochain Incorporated、R&D Systems, Inc.、Kaneka Eurogentec SA、Fortis Life Sciences、Precision Antibody、Biocytogen Pharmaceuticals、Abgenc​​an、Creative Technologieslabs、Agilc​​yas、Abgen​​ytorys、Abgenptory、Creative 地区、Agilc​​ytorys、Abgenctory.这些公司正在采用扩张、产品创新以及併购等策略来增强其市场份额，并为客户提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：北美客製化抗体服务市场概况

  • 概述
  • PEST分析

第五章：北美客製化抗体服务市场－主要市场动态

  • 市场驱动因素
    • 慢性病盛行率不断上升
    • 生物相似药核准数量不断上升
  • 市场限制
    • 利用基因改造动物生产抗体的高成本和复杂性
  • 市场机会
    • 新兴经济体及已开发经济体政府研发活动增加
  • 未来趋势
    • 利用重组抗体的技术进步
  • 驾驶员和安全带的影响：

第六章：客製化抗体服务市场－北美分析

  • 2021-2031年北美客製化抗体服务市场收入
  • 北美客製化抗体服务市场预测分析

第七章：北美客製化抗体服务市场分析－依最终用户划分

  • 生命科学产业
  • 製药和生物技术公司
  • 学术和研究机构
  • 合约研究组织

第八章：北美客製化抗体服务市场分析－依疾病指征划分

  • 肿瘤学
  • 传染病
  • 免疫学
  • 心血管疾病
  • 其他的

第九章：北美客製化抗体服务市场分析－依来源划分

  • 鸡
  • 兔子
  • 老鼠
  • 天竺鼠
  • 小鼠或人源化小鼠
  • 其他的

第十章：北美客製化抗体服务市场分析－以小鼠或人源化小鼠划分

  • 单株抗体平台
  • BsAb发现平台
  • 双特异性抗体药物偶联平台
  • TCR模拟抗体平台
  • 抗GPCR抗体技术平台
  • 其他的

第十一章：北美客製化抗体服务市场分析－按应用领域划分

  • 免疫组织化学（IHC）
  • Western Blot 和免疫沉淀
  • 酵素连结免疫吸附试验
  • 萤光活化细胞分选（FACS）
  • 质谱分析
  • 其他的

第十二章：北美客製化抗体服务市场分析－依服务类型划分

  • 抗体发现与开发
  • 抗体生产服务
  • 其他的

第十三章：北美客製化抗体服务市场分析－依产品类型划分

  • 单株抗体
  • 多株抗体杂交瘤
  • 重组抗体
  • 其他的

第十四章：北美客製化抗体服务市场－国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第十五章：客製化抗体服务市场－产业概况

  • 概述
  • 客製化抗体服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十六章：公司简介

  • Thermo Fisher Scientific Inc
  • Sino Biological Inc.
  • GenScript Biotech Corporation
  • Biochain Incorporated
  • R&D Systems, Inc
  • Kaneka Eurogentec S.A.
  • Fortis Life Sciences
  • Precision Antibody (A&G Pharmaceutical, Inc.)
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Abgenex
  • Creative Biolabs Inc
  • Agilent Technologies Inc
  • Bioklone
  • Scantibodies Laboratory, Inc.

第十七章：附录

Product Code: BMIRE00032161

The North America custom antibody services market is projected to grow significantly, reaching approximately US$ 577.76 million by 2031, up from US$ 287.49 million in 2023, with an estimated compound annual growth rate (CAGR) of 9.1% from 2023 to 2031.

Executive Summary and Market Analysis

The custom antibody services market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are driving the growth of this market, including the increasing adoption of advanced technologies, rising investments in drug discovery and development, strong government support for clinical research, and a surge in research activities in clinical diagnostics. Additionally, collaborations between government bodies and market players are promoting the use of custom antibodies in clinical diagnostics. The growing number of cancer and genomic research initiatives in the US and Canada, along with a focus on developing antibody-based therapeutics, are also contributing to market expansion. The demand for high-quality research tools to ensure data reproducibility further supports the growth of the custom antibody services market in North America.

Market Segmentation Analysis

The North America custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

  • Product Type: The market is categorized into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
  • Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
  • Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the most significant application in 2023.
  • Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
  • Source: This includes chicken, rabbits, rats, guinea pigs, and mouse or humanized mice, with the latter holding the largest share in 2023. This segment is further divided into various platforms for monoclonal antibodies and other technologies.
  • End User: The end users include the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life sciences industry leading in market share in 2023.

Market Outlook

The FDA plays a crucial role in approving biosimilar products, which enhances patient care by providing more medication options at potentially lower costs. Recent approvals of biosimilars, such as Alymsys and Cimerli, have been significant in expanding treatment options. The increasing number of biosimilars approved by the FDA is expected to drive the growth of the custom antibody services market, as they can lower treatment costs and improve access to biologic therapies.

Country Insights

The North American custom antibody services market is primarily driven by the US, which accounted for the largest share in 2023. The rising incidence of infectious, chronic, and autoimmune diseases in the US is increasing the demand for custom antibody services. Cancer remains a leading cause of death, with over 1.9 million new cases diagnosed in 2022, and projections suggest around 2.0 million new diagnoses in 2024. Custom antibodies are essential in cancer treatment for detecting tumor-specific antigens and monitoring patient progress. The US market benefits from increased R&D efforts and the growing use of custom antibodies across various research fields, including oncology and immunology.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs, Agilent Technologies, Bioklone, and Scantibodies Laboratory, Inc. These companies are employing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Custom Antibody Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Custom Antibody Services Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Approvals of Biosimilars
  • 5.2 Market Restraints
    • 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
  • 5.3 Market Opportunities
    • 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements Using Recombinant Antibodies
  • 5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - North America Analysis

  • 6.1 North America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Custom Antibody Services Market Forecast Analysis

7. North America Custom Antibody Services Market Analysis - by End User

  • 7.1 Life Science Industry
    • 7.1.1 Overview
    • 7.1.2 Life Science Industry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pharmaceutical and Biotech Companies
    • 7.2.1 Overview
    • 7.2.2 Pharmaceutical and Biotech Companies: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Academic and Research Institutes
    • 7.3.1 Overview
    • 7.3.2 Academic and Research Institutes: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Contract Research Organizations
    • 7.4.1 Overview
    • 7.4.2 Contract Research Organizations: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Custom Antibody Services Market Analysis - by Disease Indication

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Oncology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Infectious Diseases
    • 8.2.1 Overview
    • 8.2.2 Infectious Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Immunology
    • 8.3.1 Overview
    • 8.3.2 Immunology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Cardiovascular Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Custom Antibody Services Market Analysis - by Source

  • 9.1 Chicken
    • 9.1.1 Overview
    • 9.1.2 Chicken: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Rabbits
    • 9.2.1 Overview
    • 9.2.2 Rabbits: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Rats
    • 9.3.1 Overview
    • 9.3.2 Rats: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.4 Guinea Pigs
    • 9.4.1 Overview
    • 9.4.2 Guinea Pigs: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.5 Mouse or Humanized Mice
    • 9.5.1 Overview
    • 9.5.2 Mouse or Humanized Mice: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

  • 10.1 Monoclonal Antibody Platform
    • 10.1.1 Overview
    • 10.1.2 Monoclonal Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 BsAb Discovery Platform
    • 10.2.1 Overview
    • 10.2.2 BsAb Discovery Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Bispecific ADC Platform
    • 10.3.1 Overview
    • 10.3.2 Bispecific ADC Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 TCR-Mimic Antibody Platform
    • 10.4.1 Overview
    • 10.4.2 TCR-Mimic Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Anti-GPCR Antibody Technology Platform
    • 10.5.1 Overview
    • 10.5.2 Anti-GPCR Antibody Technology Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Custom Antibody Services Market Analysis - by Application

  • 11.1 Immunohistochemistry (IHC)
    • 11.1.1 Overview
    • 11.1.2 Immunohistochemistry (IHC): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.2 Western Blot and IP
    • 11.2.1 Overview
    • 11.2.2 Western Blot and IP: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.3 ELISA
    • 11.3.1 Overview
    • 11.3.2 ELISA: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.4 Fluorescence-activated cell sorting (FACS)
    • 11.4.1 Overview
    • 11.4.2 Fluorescence-activated cell sorting (FACS): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.5 Mass Spectrometry
    • 11.5.1 Overview
    • 11.5.2 Mass Spectrometry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. North America Custom Antibody Services Market Analysis - by Service Type

  • 12.1 Antibody Discovery and Development
    • 12.1.1 Overview
    • 12.1.2 Antibody Discovery and Development: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 12.2 Antibody Production Services
    • 12.2.1 Overview
    • 12.2.2 Antibody Production Services: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 12.3 Others
    • 12.3.1 Overview
    • 12.3.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. North America Custom Antibody Services Market Analysis - by Product Type

  • 13.1 Monoclonal
    • 13.1.1 Overview
    • 13.1.2 Monoclonal: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.2 Polyclonal hybridoma
    • 13.2.1 Overview
    • 13.2.2 Polyclonal hybridoma: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.3 Recombinant antibody
    • 13.3.1 Overview
    • 13.3.2 Recombinant antibody: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.4 Others
    • 13.4.1 Overview
    • 13.4.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. North America Custom Antibody Services Market - Country Analysis

  • 14.1 North America
    • 14.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
      • 14.1.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
      • 14.1.1.2 United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.2.1 United States: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.2.2 United States: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.2.3 United States: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.2.4 United States: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.2.5 United States: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.2.6 United States: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.2.7 United States: North America Custom Antibody Services Market Share - by Product Type
      • 14.1.1.3 Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.3.1 Canada: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.3.2 Canada: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.3.3 Canada: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.3.4 Canada: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.3.5 Canada: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.3.6 Canada: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.3.7 Canada: North America Custom Antibody Services Market Share - by Product Type
      • 14.1.1.4 Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.4.1 Mexico: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.4.2 Mexico: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.4.3 Mexico: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.4.4 Mexico: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.4.5 Mexico: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.4.6 Mexico: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.4.7 Mexico: North America Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

  • 15.1 Overview
  • 15.2 Growth Strategies in Custom Antibody Services Market
  • 15.3 Organic Growth Strategies
    • 15.3.1 Overview
  • 15.4 Inorganic Growth Strategies
    • 15.4.1 Overview

16. Company Profiles

  • 16.1 Thermo Fisher Scientific Inc
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Sino Biological Inc.
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 GenScript Biotech Corporation
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Biochain Incorporated
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 R&D Systems, Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 Kaneka Eurogentec S.A.
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Fortis Life Sciences
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Abgenex
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 Creative Biolabs Inc
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Agilent Technologies Inc
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Bioklone
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Scantibodies Laboratory, Inc.
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments

17. Appendix

  • 17.1 About The Insight Partners
  • 17.2 Glossary of Terms

List Of Tables

  • Table 1. North America Custom Antibody Services Market Segmentation
  • Table 2. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 4. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Indication
  • Table 5. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 7. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 8. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 9. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 10. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 11. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 12. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 13. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 14. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 15. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 16. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 17. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 18. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 20. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 21. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 22. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 23. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 25. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 26. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 27. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 28. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 29. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 30. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 31. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 32. Recent Organic Growth Strategies in Custom Antibody Services Market
  • Table 33. Recent Inorganic Growth Strategies in the Custom Antibody Services Market
  • Table 34. Glossary of Terms, Custom Antibody Services Market

List Of Figures

  • Figure 1. North America Custom Antibody Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Custom Antibody Services Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Custom Antibody Services Market Share (%) - by End User (2023 and 2031)
  • Figure 7. Life Science Industry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Pharmaceutical and Biotech Companies: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Academic and Research Institutes: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Contract Research Organizations: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Custom Antibody Services Market Share (%) - by Disease Indication (2023 and 2031)
  • Figure 12. Oncology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Infectious Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Immunology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Cardiovascular Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. North America Custom Antibody Services Market Share (%) - by Source (2023 and 2031)
  • Figure 18. Chicken: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Rabbits: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Rats: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Guinea Pigs: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Mouse or Humanized Mice: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. North America Custom Antibody Services Market Share (%) - by Mouse Or Humanized Mice (2023 and 2031)
  • Figure 25. Monoclonal Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. BsAb Discovery Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Bispecific ADC Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. TCR-Mimic Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Anti-GPCR Antibody Technology Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. North America Custom Antibody Services Market Share (%) - by Application (2023 and 2031)
  • Figure 32. Immunohistochemistry (IHC): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Western Blot and IP: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. ELISA: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Fluorescence-activated cell sorting (FACS): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Mass Spectrometry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. North America Custom Antibody Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 39. Antibody Discovery and Development: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Antibody Production Services: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. North America Custom Antibody Services Market Share (%) - by Product Type (2023 and 2031)
  • Figure 43. Monoclonal: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. Polyclonal hybridoma: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Recombinant antibody: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. North America Custom Antibody Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 48. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 49. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 50. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 51. Growth Strategies in Custom Antibody Services Market